VHR Inhibitors

VHR inhibitors, short for Vaccinia H1-related phosphatase inhibitors, represent a class of small molecules designed to target and modulate the activity of the Vaccinia H1-related phosphatase (VHR) enzyme. VHR is a member of the dual-specificity protein phosphatase (DUSP) family, which plays a pivotal role in the regulation of cellular signaling pathways. These inhibitors are primarily developed for research tools to probe and better understand the intricacies of cellular signal transduction processes. The VHR enzyme, like other DUSPs, is responsible for dephosphorylating both tyrosine and threonine residues in its substrate proteins. By doing so, VHR can modulate the activity of critical signaling molecules, such as mitogen-activated protein kinases (MAPKs), and thus influence various cellular responses, including proliferation, differentiation, and stress responses. VHR inhibitors are designed to interact with the active site of VHR, either through competitive or allosteric mechanisms, effectively preventing the dephosphorylation of specific substrates. This targeted inhibition allows researchers to dissect the contributions of VHR to signal transduction pathways and gain insights into its role in various cellular processes.